Analysts expect Core Scientific to report Q3 2026 revenue of approximately $196.85 million and a consensus EPS loss of $0.04, with the current stock price of $14.24 trading significantly below the $31.93 average price target.
Investors are primarily focused on the operational progress of the company's high-performance computing (HPC) conversion program and the timeline for its massive 500-megawatt capacity contract with CoreWeave.
Management's ability to successfully transition infrastructure from legacy Bitcoin mining to high-density AI hosting is considered the critical driver for a multi-year valuation re-rating.
Recent performance has been impacted by infrastructure build-out delays and broader AI sector volatility, but analysts remain optimistic regarding the high-margin revenue potential from the fully commissioned data center sites.